Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Heart failure

Cardioprotective effects of glatiramer acetate after ischemic myocardial injury

Nature Cardiovascular Research volume 3, pages 1024–1025 (2024)Cite this article

Subjects

Glatiramer acetate, a drug with an established history of treating multiple sclerosis in clinical practice, improves cardiac function in rodent models of myocardial infarction and ischemic heart failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: GA, a known drug treatment for MS, enhances cardiac function in rodent models of myocardial injury.

References

  1. Arnon, R. & Aharoni, R. Isr. Med. Assoc. J. 21, 151–157 (2019).

    PubMed  Google Scholar 

  2. Fridkis-Hareli, M. et al. Proc. Natl Acad. Sci. USA 91, 4872–4876 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hong, J., Li, N., Zhang, X., Zheng, B. & Zhang, J. Z. Proc. Natl Acad. Sci. USA 102, 6449–6454 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Weber, M. S. et al. Brain. 127, 1370–1378 (2004).

    Article  PubMed  Google Scholar 

  5. Hilgendorf, I. et al. Circ. Res. 134, 1718–1751 (2024).

    Article  CAS  PubMed  Google Scholar 

  6. Steffens, S. et al. Eur. Heart J. 43, 1533–1541 (2022).

    Article  CAS  PubMed  Google Scholar 

  7. Weiss, E., Ramos, G. C. & Delgobo, M. Front. Immunol. 13, 914033 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sansonetti, M., Al Soodi, B., Thum, T. & Jung, M. Basic Res. Cardiol. 119, 1–33 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Aviel, G. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-024-00524-x (2024).

    Article  PubMed  Google Scholar 

  10. Schnitter, F. et al. Basic Res. Cardiol. 119, 453–479 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany

    Ulrich Hofmann & Stefan Frantz

Authors
  1. Ulrich Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefan Frantz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Hofmann.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hofmann, U., Frantz, S. Cardioprotective effects of glatiramer acetate after ischemic myocardial injury. Nat Cardiovasc Res 3, 1024–1025 (2024). https://doi.org/10.1038/s44161-024-00517-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-024-00517-w

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research